Rise Advisors, LLC Glaukos Corp Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 95 shares of GKOS stock, worth $8,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95
Previous 95
-0.0%
Holding current value
$8,041
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
358Shares Held
51MCall Options Held
252KPut Options Held
771K-
Black Rock Inc. New York, NY8.04MShares$680 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$505 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$168 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$165 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.03B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...